The toxicity of Salmonella typhosa 0901 
Since Berry (1) observed that actinomycin D sensitizes mice to bacterial endotoxin, several investigators have noted that a number of antitumor drugs render laboratory animals more susceptible to bacterial endotoxin (5, 8, 11) . Because of the clinical utility of some of these drugs, it is important to determine whether antitumor drugs generally alter an animal's susceptibility to endotoxin, and to determine the intensity of the hyperreactivity induced by a drug. In this study, the ability of L-asparaginase, cyclophosphamide, daunomycin, methotrexate, pactamycin, polyinosinicpolycytidylic acid (poly I:C), procarbazine, and vincristine to enhance endotoxin lethality in mice was measured.
Vincristine was selected as an exemplary antitumor drug for further study because of its clinical importance (13) . One of the crucial questions concerning a drug-induced hyperreactivity to endotoxin is whether endogenous bacteria can serve as a source of the bacterial toxin. The capability of live and heat-killed Escherichia coli cells to substitute for bacterial endotoxin in the lethal synergy involving actinomycin D has been demonstrated (11) . Because Pseudomonas is a component of the normal flora of some strains of mice (12) and because of the increasing incidence of Pseudomonas infections in cancer patients (14) , the capability of this bacterium to enhance the lethality of vincristine for mice was tested. Additional studies were undertaken to define the nature of the vincristine-endotoxin synergy. Pretreatment of mice with endotoxin or phenobarbital mitigated the toxicity of vincristine and endotoxin.
MATERIALS AND METHODS BALB/c male mice weighing 20 to 25 g were used. Except for poly I:C (P-L Biochemicals, Inc., Milwaukee, Wis.), all drug solutions were prepared such that the required amount could be administered intraperitoneally (ip) in 0.01 ml per g of mouse weight. L-Asparaginase (Merck, Sharpe Probit analyses of data leading to LDw determinations, tests for parallelism, and calculation of potency ratios were done by the method of Litchfield and Wilcoxon (9) .
The strain of P. aeruginosa employed in these studies was isolated from BALB/c mouse feces. The culture was maintained on Nutrient Agar (Difco). Cultures grown in peptone-yeast extract (0.5 and 0.3%, respectively) broth for 18 hr at 37 C were harvested by centrifugation and suspended in sterile saline. The cell suspensions were heated in a water bath at 58 C for 1 hr. Five per cent (w/v) liver homogenates were prepared in 0.02 M phosphate-buffered saline adjusted to pH 7.4. Homogenizations were performed in a Teflon pestle-glass tube, Potter-Elvehjem type system maintained at ca. 5 C. The homogenate was centrifuged at 1,000 X g for 10 min, and the resulting supernatant fraction was subsequently used. Samples of the liver homogenates (4 ml) were added to 25-ml Erlenmeyer flasks containing 1 ml of 75 ,ug of endotoxin per ml of saline. These mixtures were incubated for 3 hr at 37 C in a Dubnoff-metabolic shaker oscillating at 100 motions per min and were left exposed to the atmosphere. Control samples were treated similarly, except that they were incubated at 4 C.
Residual endotoxin in the incubation mixtures was assayed by a modification of the methods of Pieroni et al. (10) and Dowling and Feldman (4) . The incubated samples were administered to mice previously stressed with 0.8 mg of actinomycin D per kg. The negative control serving as the standard for no inactivation of endotoxin consisted of the complete reaction mixture incubated at 4 C. The significance of differences between the proportion of dead mice in the test groups and the control group was evaluated by the chi square test.
RESULTS
Of the eight drugs evaluated, only L-asparaginase failed to enhance endotoxin lethality significantly ( Table 1 ). The LD,% of endotoxin increased from 18.3 mg per kg to 26.0 mg per kg when mice were simultaneously administered 20,000 international units of L-asparaginase per kg. The slope of the lethal responses to endotoxin in L-asparaginase-treated animals was parallel to the slope of the lethal responses to endotoxin alone but was not significantly displaced (P > 0.05). The potentiations of endotoxin lethality occurring in mice simultaneously receiving 375 mg of cyclophosphamide per kg, 16 mg of daunomycin per kg, 80 (Table 1) . These potentiations occurred in a parallel manner when cyclophosphamide, poly I:C, or procarbazine was the potentiating drug (Table 1) .
The diagrammatic presentation of data for the vincristine potentiation of endotoxin lethality ( Fig. 1) is representative of the data from which the summary results were obtained ( Table 1 b Significance determined at P < 0.01 by a "one-tailed" t test.
c This dose of procarbazine alone was not sedative although greater doses, e.g. 1,000 mg per kg, did cause sedation. d Mice were administered 2 mg of endotoxin per kg on day -6, 4 mg per kg on days -5 and -4, and 8 mg per kg on day -3; 45 mg of pentobarbital per kg was given on day 0. their control counterparts (Table 4) . Phenobarbital-pretreated mice were not sedated by a dose of pentobarbital (45 mg/kg) which was sufficient to sedate all of the control mice. It is noteworthy that this phenobarbital pretreatment failed to alter significantly (P > 0.10) the lethal response to either vincristine or endotoxin alone.
Mice whose resistance to the lethal effects of endotoxin was increased by pretreatment with endotoxin were challenged with vincristine with or without simultaneous endotoxin administration (Fig. 2) . Normal mice given 16 mg of endotoxin per kg experienced 42% lethality 3 days after challenge, whereas pretreated animals suffered only 20% lethality. The LDw of vincristine for normal animals during this experimentation, as determined by probit analysis of data recorded 3 days after challenge, was 7.7 mg/kg. Using (Fig. 3) . The LD20 of vincristine, determined by probit analysis of data collected 3 days after challenge, was reduced from 10.0 mg per kg to 2.8 mg per kg when the drug was given with 9.4 X 108 heatkilled cells per kg. This significant 3.6-fold potentiation occurred in a parallel manner. Similarly, the concurrent administration of 1.9 X 108 heatkilled cells per kg with vincristine resulted in a significant 1.8-fold potentiation of vincristine lethality (LD50 changed from 10.0 mg of vincristine per kg to 5.7 mg of vincristine per kg), which occurred in a parallel manner. Control mice receiving 9.4 x 108 heat-killed cells per kg did not die.
The ability of liver homogenates from mice previously treated with vincristine to inactivate endotoxin is shown in Table 5 . Vincristine, 4 mg per kg, was given to mice 24 hr prior to excision of their livers. The livers from vincristine-treated mice were subjected to the same handling as normal livers. Endotoxin incubated in 5% normal liver homogenates at 37 C for 3 hr was significantly (P < 0.01) inactivated compared to endotoxin incubated at 4 C. Similarly, 5 % liver homogenates from vincristine-treated mice significantly (P < 0.05) inactivated endotoxin.
.5 .-. Prolongation of barbiturate-induced sedation indicates that the hepatic microsomal mixedfunction oxidase activity has decreased, either as a subtle effect on enzyme activity, stability, or synthesis, or as a generalized cytotoxic effect. It should be noted that barbiturate sedation was prolonged by all of the tested antitumor drugs, including L-asparaginase, which did not potentiate the toxicity of bacterial endotoxin. From these results, it may be inferred that the hyperreactivity to endotoxin provoked by selected antitumor drugs was not causally related to reduced microsomal oxidase activity. A corollary of this conclusion is that mixed-function oxidase enzymes are not normally responsible for the detoxification of endotoxin. In support of this view is the observation that mice rendered resistant to endotoxin have impaired capability to metabolize pentobarbital. Our interpretation is consistent with that of Filkins (6) , who found that the lysosomal fraction of the liver possessed the greatest capability to inactivate endotoxin.
It was observed that pentobarbital-induced sedation in mice was prolonged to the same extent when the barbiturate was given simultaneously or 1 day after vincristine administration. Accordingly, if vincristine is metabolized by microsomal enzymes, the deleterious action of vincristine must be manifested immediately and persist for many hours. Because mice given vincristine prior to endotoxin were not killed as extensively as mice given vincristine and endotoxin simultaneously, it may be inferred that vincristine is not acting primarily by preventing the clearance or detoxification of endotoxin. This conclusion is supported by the observation that liver homogenates from vincristine-treated mice detoxified endotoxin in vitro to approximately the same extent as liver homogenates from normal mice.
The inhibition of microsomal enzymes by endotoxin, which is indicated by an increase in the duration of pentobarbital-induced sedation, could however, account for the enhanced lethality of combinations of endotoxin and drug if hepatic microsomal mixed-function oxidase activity was related to or correlated with capability to degrade vincristine. Because the prolongation of barbiturate-induced sedation begins to fade 2 days after endotoxin administration, and because death due to vincristine alone is delayed, it would be expected that there would be fewer deaths when endotoxin was given before vincristine as compared with the incidence of deaths when the two agents were given simultaneously. This prediction is supported by the data presented.
Additional confirmation of the hypothesis that endotoxin hampers the clearance or detoxification of vincristine is provided by experiments involving endotoxin-pretreated mice. It is significant that endotoxin-pretreated mice have prolonged barbiturate-induced sleeping times. Moreover, endotoxin-pretreated mice are more vulnerable to the lethal action of vincristine alone than are normal mice. These results corroborate the proposition that vincristine is metabolized by hepatic microsomal enzymes. Nevertheless, endotoxin-pretreated mice were protected against vincristineendotoxin challenges despite an even greater susceptibility towards vincristine alone. A further indication that vincristine is metabolized by hepatic microsomal enzymes, whose activity is somehow reduced by endotoxin, is the observation that mice pretreated with phenobarbital, an inducer of microsomal enzymes (7), experienced significant reductions in lethality due to combinations of vincristine and endotoxin.
In light of the increasing reports of Pseudomonas infections in patients with malignant disease (14) , and because of the abundant source of gram-negative bacteria and hence endotoxin present within the mammalian gastrointestinal tract (3), the demonstration of an interaction of gramnegative bacteria and antitumor drugs has implications of clinical importance. (11) . The significant potentiation of vincristine lethality by heat-killed P. aeruginosa cells derived from the mouse corroborates our view that drug-endotoxin interactions should be considered as a possible explanation for some of the adverse reactions observed in patients receiving antitumor drugs.
